Sawgrass Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,147
Closed -$287K 175
2020
Q4
$287K Sell
1,147
-162
-12% -$38.6K 0.02% 134
2020
Q3
$296K Sell
1,309
-1,251
-49% -$260K 0.02% 134
2020
Q2
$446K Sell
2,560
-65
-2% -$10.4K 0.03% 102
2020
Q1
$331K Buy
+2,625
New +$394K 0.03% 114
2019
Q2
Sell
-3,740
Closed -$543K 175
2019
Q1
$543K Buy
3,740
+475
+15% +$62.4K 0.02% 149
2018
Q4
$370K Buy
3,265
+365
+13% +$45.7K 0.02% 159
2018
Q3
$390K Hold
2,900
0.02% 175
2018
Q2
$326K Buy
2,900
+720
+33% +$77.8K 0.01% 193
2018
Q1
$233K Sell
2,180
-9,215
-81% -$993K 0.01% 195
2017
Q4
$1.25M Sell
11,395
-2,620
-19% -$285K 0.06% 113
2017
Q3
$1.51M Buy
14,015
+6,615
+89% +$680K 0.07% 87
2017
Q2
$749K Buy
+7,400
New +$681K 0.03% 115
2015
Q2
Sell
-3,850
Closed -$305K 122
2015
Q1
$305K Buy
+3,850
New +$284K 0.01% 103

Other funds holding CRL

Sawgrass Asset Management's CRL Position: Q1 2021 in Review

Sawgrass Asset Management sold out of Charles River Laboratories (CRL) in Q1 2021, closing a stake of 1,147 shares — an estimated $287K sold.

Sawgrass Asset Management first reported a position in CRL in Q1 2015 and held it in 13 quarters. The position peaked at $1.51M in Q3 2017. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2021.

  • Sawgrass Asset Management reported no remaining Charles River Laboratories position as of Q1 2021 after selling out during the quarter.
  • Sawgrass Asset Management sold 1,147 Charles River Laboratories shares in Q1 2021, an estimated $287K.
  • Sawgrass Asset Management first reported a position in Charles River Laboratories in Q1 2015 and held it in 13 quarters.
  • Sawgrass Asset Management's Charles River Laboratories position peaked at $1.51M in Q3 2017.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2021.

Based on Sawgrass Asset Management's 13F filing for Q1 2021, filed 29 Apr 2021.